RESUMO
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, and activation of CD8(+) T cells is crucial for a protective immune response. Therefore, the identification of antigens with major histocompatibility complex class I epitopes is a crucial step for vaccine development against T. cruzi. Our aim was to identify novel antigens and epitopes by immunoinformatics analysis of the parasite proteome (12 969 proteins) and to validate their immunotherapeutic potential in infected mice. We identified 172 predicted epitopes, using NetMHC and RANKPEP. The corresponding protein sequences were reanalyzed to generate a consensus prediction, and 26 epitopes were selected for in vivo validation. The interferon γ (IFN-γ) recall response of splenocytes from T. cruzi-infected mice confirmed that 10 of 26 epitopes (38%) induced IFN-γ production. The immunotherapeutic potential of a mixture of all 10 peptides was evaluated in infected mice. The therapeutic vaccine was able to control T. cruzi infection, as evidenced by reduced parasitemia, cardiac tissue inflammation, and parasite burden and increased survival. These findings illustrate the benefits of this approach for the rapid development of a vaccine against pathogens with large genomes. The identified peptides and the proteins from which they are derived are excellent candidates for the development of a vaccine against T. cruzi.
Assuntos
Doença de Chagas/prevenção & controle , Doença de Chagas/terapia , Biologia Computacional , Vacinas Protozoárias/imunologia , Vacinas Protozoárias/isolamento & purificação , Trypanosoma cruzi/genética , Trypanosoma cruzi/imunologia , Animais , Antígenos de Protozoários/genética , Antígenos de Protozoários/imunologia , Modelos Animais de Doenças , Epitopos de Linfócito T/genética , Epitopos de Linfócito T/imunologia , Interferon gama/metabolismo , Leucócitos Mononucleares/imunologia , Camundongos Endogâmicos BALB C , Miocárdio/patologia , Carga Parasitária , Parasitemia/prevenção & controle , Parasitemia/terapia , Baço/imunologia , Análise de SobrevidaRESUMO
BACKGROUND: Chagas disease (CD) is caused by Trypanosoma cruzi and affects 6-7 million people worldwide. Approximately 30% of chronic patients develop chronic chagasic cardiomyopathy (CCC) after decades. Benznidazole (BNZ), one of the first-line chemotherapy used for CD, induces toxicity and fails to halt the progression of CCC in chronic patients. The recombinant parasite-derived antigens, including Tc24, Tc24-C4, TSA-1, and TSA-1-C4 with Toll-like receptor 4 (TLR-4) agonist-adjuvants reduce cardiac parasite burdens, heart inflammation, and fibrosis, leading us to envision their use as immunotherapy together with BNZ. Given genetic immunization (DNA vaccines) encoding Tc24 and TSA-1 induce protective immunity in mice and dogs, we propose that immunization with the corresponding recombinant proteins offers an alternative and feasible strategy to develop these antigens as a bivalent human vaccine. We hypothesized that a low dose of BNZ in combination with a therapeutic vaccine (TSA-1-C4 and Tc24-C4 antigens formulated with a synthetic TLR-4 agonist-adjuvant, E6020-SE) given during early chronic infection, could prevent cardiac disease progression and provide antigen-specific T cell immunity. METHODOLOGY/ PRINCIPAL FINDINGS: We evaluated the therapeutic vaccine candidate plus BNZ (25 mg/kg/day/7 days) given on days 72 and 79 post-infection (p.i) (early chronic phase). Fibrosis, inflammation, and parasite burden were quantified in heart tissue at day 200 p.i. (late chronic phase). Further, spleen cells were collected to evaluate antigen-specific CD4+ and CD8+ T cell immune response, using flow cytometry. We found that vaccine-linked BNZ treated mice had lower cardiac fibrosis compared to the infected untreated control group. Moreover, cells from mice that received the immunotherapy had higher stimulation index of antigen-specific CD8+Perforin+ T cells as well as antigen-specific central memory T cells compared to the infected untreated control. CONCLUSIONS: Our results suggest that the bivalent immunotherapy together with BNZ treatment given during early chronic infection protects BALB/c mice against cardiac fibrosis progression and activates a strong CD8+ T cell response by in vitro restimulation, evidencing the induction of a long-lasting T. cruzi-immunity.
Assuntos
Doença de Chagas , Vacinas Protozoárias , Trypanosoma cruzi , Vacinas de DNA , Adjuvantes Imunológicos , Animais , Doença de Chagas/tratamento farmacológico , Cães , Fibrose , Humanos , Inflamação/tratamento farmacológico , Camundongos , Camundongos Endogâmicos BALB C , Nitroimidazóis , Perforina , Proteínas Recombinantes , Receptor 4 Toll-Like , Trypanosoma cruzi/genética , Vacinas Combinadas/uso terapêuticoRESUMO
About 6.5 million people worldwide are afflicted by Chagas disease, which is caused by the protozoan parasite Trypanosoma cruzi. The development of a therapeutic vaccine to prevent the progression of Chagasic cardiomyopathy has been proposed as an alternative for antiparasitic chemotherapy. Bioinformatics tools can predict MHC class I CD8 + epitopes for inclusion in a single recombinant protein with the goal to develop a multivalent vaccine. We expressed a novel recombinant protein Tc24-C4.10E harboring ten nonameric CD8 + epitopes and using Tc24-C4 protein as scaffold to evaluate the therapeutic effect in acute T. cruzi infection. T. cruzi-infected mice were immunized with Tc24-C4.10E or Tc24-C4 in a 50-day model of acute infection. Tc24-C4.10E-treated mice showed a decreased parasitemia compared to the Tc24-C4 (non-adjuvant) immunized mice or control group. Moreover, Tc24-C4.10E induced a higher stimulation index of CD8 + T cells producing IFNγ and IL-4 cytokines. These results suggest that the addition of the MHC Class I epitopes to Tc24-C4 can synergize the antigen-specific cellular immune responses, providing proof-of-concept that this approach could lead to the development of a promising vaccine candidate for Chagas disease.
Assuntos
Doença de Chagas , Proteínas de Protozoários , Trypanosoma cruzi , Animais , Camundongos , Anticorpos Antiprotozoários , Antiparasitários/uso terapêutico , Linfócitos T CD8-Positivos , Doença de Chagas/prevenção & controle , Citocinas , Epitopos , Interleucina-4 , Camundongos Endogâmicos BALB C , Proteínas de Protozoários/imunologia , Vacinas Protozoárias , Proteínas Recombinantes , Trypanosoma cruzi/imunologia , Vacinas CombinadasRESUMO
OBJECTIVE: Chagas disease is a major vector-borne parasitic disease in Latin America, primarily transmitted to humans by triatomine vectors. Non-domiciliated triatomine species such as Triatoma dimidiata in the Yucatan peninsula, Mexico, can transiently invade houses and are emerging as a major challenge to control Trypanosoma cruzi transmission to humans. We analyzed the spatio-temporal spreading of house infestation by T. dimidiata in four rural villages. METHODS: Triatomines were collected in four rural villages over a 2 years period, and the spatio-temporal patterns of infestation were analyzed. RESULTS: Triatomines were consistently more abundant at the periphery of villages than in centers, indicating a much higher risk of T. cruzi transmission at the periphery. Male T. dimidiata were found further in the center of the village, while females remained closer to the periphery, suggesting differential dispersal capabilities between sexes, although the timing of dispersal appeared identical. Surprisingly, infected females were consistently collected in houses much further from the surrounding bushes than non-infected females, while the distribution of males was unaffected by their T. cruzi infection status, suggesting an increased dispersal capability in infected females. CONCLUSION: The spatial structure of infestation should be taken into account for the prioritization of vector control activities within villages, and spatially targeted interventions may be explored. A potential vector manipulation by T. cruzi, observed for the first time in triatomines, may favor parasite transmission to new hosts.
Assuntos
Doença de Chagas/veterinária , Habitação/estatística & dados numéricos , Insetos Vetores/crescimento & desenvolvimento , Triatoma/crescimento & desenvolvimento , Trypanosoma cruzi/fisiologia , Animais , Doença de Chagas/epidemiologia , Doença de Chagas/transmissão , Feminino , Sistemas de Informação Geográfica , Interações Hospedeiro-Parasita , Insetos Vetores/parasitologia , Masculino , México/epidemiologia , Dinâmica Populacional , Saúde da População Rural/estatística & dados numéricos , Estações do Ano , Fatores Sexuais , Conglomerados Espaço-Temporais , Triatoma/parasitologia , Trypanosoma cruzi/isolamento & purificaçãoRESUMO
Leishmaniasis is a neglected disease with an estimated 12 million infected people. The recent completion of the sequencing of the Leishmania major genome has opened opportunities for the identification of targets for vaccine development. We present here the first attempt at identifying novel vaccine candidates by whole genome analysis. We predicted CD8(+) T cell epitopes from the L. major proteome and validated in vivo in mice the immunogenicity of some of the best predicted epitopes. Consensus epitope predictions from 8272 annotated protein sequences with 5-8 different algorithms allowed the identification of 78 class I CD8(+) epitopes. BALB/c mice were immunized with 26 synthetic peptides corresponding to the most likely epitopes. Fourteen (54%) resulted immunogenic, with eight being strong inducers of T cell IFNgamma production. None of the proteins from which the epitopes are derived are differentially expressed, only two may be surface proteins, eight have putative enzymatic, and metabolic activities. These epitopes and proteins represent new antigen candidates for further studies. While pathogen genomes have not yet delivered their full promise in terms of human health applications, our study opens the way for extensive genome mining for antigen identification and vaccine development against Leishmania and other pathogens.
Assuntos
Biologia Computacional/métodos , Epitopos de Linfócito T/imunologia , Leishmania major/imunologia , Proteoma/análise , Proteoma/imunologia , Vacinas/imunologia , Animais , Linfócitos T CD8-Positivos/imunologia , Epitopos de Linfócito T/análise , Epitopos de Linfócito T/genética , Genoma , Humanos , Leishmania major/genética , Camundongos , Camundongos Endogâmicos BALB C , Peptídeos/administração & dosagem , Peptídeos/química , Peptídeos/imunologia , VacinaçãoRESUMO
Chagas disease is caused by Trypanosoma cruzi and dogs are an important reservoir of the parasite as well as a good model for the study of the pathogenesis of the disease. We aimed here at characterizing the immunopathology of naturally infected dogs in Merida, Yucatan, Mexico. Following an initial screening for T. cruzi seropositive stray dogs, we examined 9 seropositive and 10 seronegative animals. High lymphocytes and low monocytes counts were observed in peripheral blood from seropositives dogs. Three of nine seropositive dogs presented electrocardiographic alterations including right bundle branch block, sinusal block and QRS complex alterations and some right ventricle enlargement was noted. Histopathologic analysis of cardiac walls revealed significant inflammation with a clear tropism for the right ventricle, although most walls were affected. Seropositive dogs presented low IgG1 and high IgG2 levels. Higher IgG1 levels were associated with increased cardiac index and myocarditis, suggesting that a Th2 immune response leads to susceptibility and increased disease severity. These observations shed some light on the mechanisms of pathogenesis of Chagas disease in dogs, and provide a good framework for the evaluation of novel drugs and vaccines in this animal model.
Assuntos
Doença de Chagas/veterinária , Doenças do Cão/imunologia , Trypanosoma cruzi , Animais , Anticorpos Antiprotozoários/sangue , Doença de Chagas/imunologia , Doença de Chagas/patologia , DNA de Protozoário/análise , Doenças do Cão/patologia , Cães , Coração/parasitologia , Imunoglobulina G/sangueRESUMO
The present study aims to assess the impact of the Spanish young offenders law (LO/2000). Recidivism and its associated risk factors were used as indicators of impact. Data were collected from young offenders' reports opened after 2001 and closed before 2005. The final sample consisted of 382 young offenders (327 males and 55 females). Results indicated that 70% had not re-offended in an average period of 1.6 years. Most of the youngsters with fewer risk factors, usually start their criminal careers with less serious offences and the interventions seemed to be fairly effective. In the cases of young offenders with a higher number of risk factors, the interventions (custodial and non-custodial) were less effective, as recidivism rates were higher. Interventions must focus on family and community contexts in order to achieve adequate social integration of young delinquents.
Assuntos
Crime/legislação & jurisprudência , Delinquência Juvenil/legislação & jurisprudência , Responsabilidade Legal , Adolescente , Fatores Etários , Criança , Crime/prevenção & controle , Crime/estatística & dados numéricos , Feminino , Humanos , Delinquência Juvenil/estatística & dados numéricos , Masculino , Fatores de Risco , Delitos Sexuais/legislação & jurisprudência , Delitos Sexuais/estatística & dados numéricos , Responsabilidade Social , Espanha , Roubo/legislação & jurisprudência , Roubo/estatística & dados numéricos , Violência/legislação & jurisprudência , Violência/estatística & dados numéricosRESUMO
BACKGROUND: In the Yucatán Peninsula, Mexico, Triatoma dimidiata is the main vector of Trypanosoma cruzi, the causative agent of Chagas disease. Little effort has been made to identify blood meal sources of T. dimidiata in natural conditions in this region, although this provides key information to disentangle T. cruzi transmission cycles and dynamics and guide the development of more effective control strategies. We identified the blood meals of a large sample of T. dimidiata bugs collected in different ecotopes simultaneously with the assessment of bug infection with T. cruzi, to disentangle the dynamics of T. cruzi transmission in the region. METHODS: A sample of 248 T. dimidiata bugs collected in three rural villages and in the sylvatic habitat surrounding these villages was used. DNA from each bug midgut was extracted and bug infection with T. cruzi was assessed by PCR. For blood meal identification, we used a molecular assay based on cloning and sequencing following PCR amplification with vertebrate universal primers, and allowing the detection of multiple blood meals in a single bug. RESULTS: Overall, 28.7% of the bugs were infected with T. cruzi, with no statistical difference between bugs from the villages or from sylvatic ecotopes. Sixteen vertebrate species including domestic, synanthropic and sylvatic animals, were identified as blood meal sources for T. dimidiata. Human, dog and cow were the three main species identified, in bugs collected in the villages as well as in sylvatic ecotopes. Importantly, dog was highlighted as the main blood meal source after human. Dog was also the most frequently identified animal together with human within single bugs, and tended to be associated with the infection of the bugs. CONCLUSIONS: Dog, human and cow were identified as the main mammals involved in the connection of sylvatic and domestic transmission cycles in the Yucatán Peninsula, Mexico. Dog appeared as the most important animal in the transmission pathway of T. cruzi to humans, but other domestic and synanthropic animals, which most were previously reported as important hosts of T. cruzi in the region, were evidenced and should be taken into account as part of integrated control strategies aimed at disrupting parasite transmission.
Assuntos
Sangue , Doença de Chagas/transmissão , Triatoma/parasitologia , Trypanosoma cruzi/isolamento & purificação , Animais , Bovinos , Cães , Feminino , Humanos , Insetos Vetores/parasitologia , Insetos Vetores/fisiologia , Masculino , México , Triatoma/fisiologiaRESUMO
A therapeutic vaccine for human Chagas disease (American trypanosomiasis caused by Trypanosoma cruzi) is under development based on the success of vaccinating mice with DNA constructs expressing the antigens Tc24 and Tc-TSA-1. However, because DNA and nucleic acid vaccines produce less than optimal responses in humans, our strategy relies on administering a recombinant protein-based vaccine, together with adjuvants that promote Th1-type immunity. Here we describe a process for the purification and refolding of recombinant TSA-1 expressed in Escherichia coli. The overall yield (20-25%) and endotoxin level of the purified recombinant TSA-1 (rTSA-1) is suitable for pilot scale production of the antigen for use in phase 1 clinical trials. Mice infected with T. cruzi were treated with rTSA-1, either alone or with Toll-like receptor 4 (TLR-4) agonist adjuvants including monophosphoryl lipid A (MPLA), glucopyranosyl lipid A (GLA, IDRI), and E6020 (EISEI, Inc). TSA-1 with the TLR-4 agonists was effective at reducing parasitemia relative to rTSA-1 alone, although it was difficult to discern a therapeutic effect compared to treatment with TLR-4 agonists alone. However, rTSA-1 with a 10 ug dose of MPLA optimized reductions in cardiac tissue inflammation, which were significantly reduced compared to MPLA alone. It also elicited the lowest parasite burden and the highest levels of TSA-1-specific IFN-gamma levels and IFN-gamma/IL-4 ratios. These results warrant the further evaluation of rTSA-1 in combination with rTc24 in order to maximize the therapeutic effect of vaccine-linked chemotherapy in both mice and non-human primates before advancing to clinical development.
Assuntos
Doença de Chagas/terapia , Imunoterapia/métodos , Vacinas Protozoárias/imunologia , Glicoproteínas Variantes de Superfície de Trypanosoma/imunologia , Adjuvantes Imunológicos/administração & dosagem , Animais , Anticorpos Antiprotozoários/sangue , Doença de Chagas/imunologia , Feminino , Imunidade Celular , Camundongos , Camundongos Endogâmicos BALB C , Carga Parasitária , Parasitemia/prevenção & controle , Vacinas Protozoárias/genética , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/imunologia , Células Th1/imunologia , Glicoproteínas Variantes de Superfície de Trypanosoma/administração & dosagemRESUMO
Trypanosoma cruzi is the agent of Chagas disease, transmitted by hematophagous triatomine vectors. Establishing transmission cycles is key to understand the epidemiology of the disease, but integrative assessments of ecological interactions shaping parasite transmission are still limited. Current approaches also lack sensitivity to assess the full extent of this ecological diversity. Here we developed a metabarcoding approach based on next-generation sequencing to identify triatomine gut microbiome, vertebrate feeding hosts, and parasite diversity and their potential interactions. We detected a dynamic microbiome in Triatoma dimidiata, including 23 bacterial orders, which differed according to blood sources. Fourteen vertebrate species served as blood sources, corresponding to domestic, synantropic and sylvatic species, although four (human, dog, cow and mice) accounted for over 50% of blood sources. Importantly, bugs fed on multiple hosts, with up to 11 hosts identified per bug, indicating very frequent host-switching. A high clonal diversity of T. cruzi was detected, with up to 20 haplotypes per bug. This analysis provided much greater sensitivity to detect multiple blood meals and multiclonal infections with T. cruzi, which should be taken into account to develop transmission networks, and characterize the risk for human infection, eventually leading to a better control of disease transmission.
Assuntos
Biodiversidade , Doença de Chagas , Código de Barras de DNA Taxonômico , Insetos Vetores , Triatoma , Trypanosoma cruzi/genética , Animais , Bovinos , Doença de Chagas/genética , Doença de Chagas/transmissão , Cães , Feminino , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Insetos Vetores/genética , Insetos Vetores/parasitologia , Camundongos , Triatoma/genética , Triatoma/parasitologiaRESUMO
Non-domiciliated intrusive triatomine vectors are responsible for a low but significant transmission of Trypanosoma cruzi to humans. Their control is a challenge as insecticide spraying is of limited usefulness, and alternative strategies need to be developed for a sustainable control. We performed a non-randomized controlled trial of an Ecohealth intervention based on window insect screens and community participation to reduce house infestation by Triatoma dimidiata in two rural villages in Yucatan, Mexico. Efficacy of the intervention was measured over a three years follow-up period and entomological indicators showed that the proportion of triatomines found inside houses was significantly reduced in houses with insect screens, which effectively kept more bugs on the outside of houses. Using a previously developed model linking entomological data to the prevalence of infection in human, we predicted that the intervention would lead to a 32% reduction in yearly incidence and in the prevalence of T. cruzi infection. The cost for the coverage of all the windows of a house was of comparable magnitude to what families currently spend on various domestic insecticide, and most screens were still in good conditions after three years. In conclusion, the Ecohealth approach proposed here is effective for the long-term and sustainable control of intrusive T. dimidiata vectors in the Yucatan peninsula, Mexico. This strategy may also be easily adapted to other intrusive triatomine species as well as other regions/countries with comparable eco-epidemiological settings, and would be an excellent component of a larger integrated program for the control of a variety of other vector-borne diseases, bringing additional benefits to the communities. Our results should encourage a further scaling-up of our implementation strategy in additional villages in the region.
Assuntos
Doença de Chagas/prevenção & controle , Controle de Insetos/métodos , Triatoma/fisiologia , Trypanosoma cruzi/fisiologia , Animais , Doença de Chagas/parasitologia , Doença de Chagas/transmissão , Habitação , Humanos , Insetos Vetores/efeitos dos fármacos , Insetos Vetores/parasitologia , Insetos Vetores/fisiologia , Inseticidas/farmacologia , México , Saúde da População Rural , Triatoma/efeitos dos fármacos , Triatoma/parasitologia , Trypanosoma cruzi/efeitos dos fármacos , Trypanosoma cruzi/parasitologiaRESUMO
Compared with South America, there is a lack of epidemiologic studies about the risk of congenital transmission of Trypanosoma cruzi in Central America and Mexico. It has been suggested that T. cruzi genotypes might differ by region and that congenital transmission might vary according to the parasite's genotype. Our objective was to compare T. cruzi congenital transmission rates in three countries. We performed an observational prospective study in 2011-2014 enrolling women at delivery in one hospital in Argentina, two hospitals in Honduras, and two hospitals in Mexico. Congenital T. cruzi infection was defined as the presence of one or more of the following criteria: presence of parasites in cord blood (direct parasitological microscopic examination) with positive polymerase chain reaction (PCR) in cord blood, presence of parasites in infant's blood at 4-8 weeks (direct parasitological microscopic examination), and persistence of T. cruzi-specific antibodies at 10 months, as measured by at least two tests. Among 28,145 enrolled women, 347 had at least one antibody rapid test positive in cord blood and a positive enzyme-linked immunosorbent assay in maternal blood. PCR in maternal blood was positive in 73.2% of the cases, and genotyping identified a majority of non-TcI in the three countries. We found no (0.0%; 95% confidence interval [CI]: 0.0, 2.0) confirmed congenital case in Honduras. Congenital transmission was 6.6% (95% CI: 3.1, 12.2) in Argentina and 6.3% (95% CI: 0.8, 20.8) in Mexico. Trypanosoma cruzi non-TcI predominated and risks of congenital transmission were similar in Argentina and Mexico.
Assuntos
Doença de Chagas/transmissão , Transmissão de Doença Infecciosa/estatística & dados numéricos , Adulto , Doença de Chagas/epidemiologia , Feminino , Sangue Fetal/parasitologia , Honduras/epidemiologia , Humanos , Recém-Nascido , México/epidemiologia , Gravidez , Estudos Prospectivos , Estatísticas não Paramétricas , Trypanosoma cruzi/patogenicidadeRESUMO
In the Yucatán Peninsula of Mexico, the main vector of Chagas disease is Triatoma dimidiata. Field studies suggest that natural transmission occurs through transient and seasonal invasion of houses by sylvatic/peridomestic triatomines, rather than through persistent domiciliated bug populations. We investigated the genetic structure of T. dimidiata populations, using morphometry and microsatellite markers, to assess dispersal of individuals in this triatomine species and to understand the dynamics of domestic infestation. We observed low phenotypic and genetic differentiation among populations from different villages, with an FST of only 0.0553, which suggested a weak but significant population structure at this level. Similarly low but significant differences were observed among populations from the same village but different biotopes (sylvatic, peridomestic, and domestic), with FST values ranging from 0.0096 to 0.0455. These data suggested elevated dispersal of bugs between biotopes (Nm = 5-25), which was confirmed by likelihood and Bayesian assignment tests. A proportion of bugs collected within domiciles were significantly assigned to peridomestic and sylvatic areas. This study showed that T. dimidiata has important dispersal capabilities that can explain the seasonal pattern of domicile infestation by peridomestic and sylvatic bugs. Therefore, dispersal should be taken into account in the design of effective vector control strategies.
Assuntos
Insetos Vetores/fisiologia , Repetições de Microssatélites/genética , Triatoma/fisiologia , Animais , Doença de Chagas/transmissão , Demografia , Feminino , Frequência do Gene , Genótipo , Insetos Vetores/anatomia & histologia , Insetos Vetores/genética , Masculino , México , Triatoma/anatomia & histologia , Triatoma/genéticaRESUMO
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is a major public health problem in most of Latin America. A key priority is the development of new treatments, due to the poor efficacy of current ones. We report here the comparative evaluation of therapeutic DNA vaccines encoding various T. cruzi antigens. ICR mice infected with 500 parasites intraperitoneally were treated at 5 and 12 days postinfection with 20 microg of plasmid DNA encoding T. cruzi antigens TSA-1, TS, ASP-2-like, Tc52 or Tc24. Treatment with plasmid encoding TS and/or ASP-2-like antigens had no significant effect on parasitemia or survival. Treatment with Tc52 DNA significantly reduced parasitemia, as well as cardiac parasite burden, and improved survival, although myocarditis was not significantly affected. Finally, treatment with plasmids encoding Tc24 and TSA-1 induced the most complete control of disease as evidenced by significant reductions in parasitemia, mortality, myocarditis and heart parasite burden. These data demonstrate that therapeutic vaccine efficacy is dependent on the antigen and suggest that DNA vaccines encoding Tc24, TSA-1, and Tc52 represent the best candidates for further studies of a therapeutic vaccine against Chagas disease.
Assuntos
Cardiomiopatia Chagásica/tratamento farmacológico , Doença de Chagas/tratamento farmacológico , Vacinas Protozoárias/uso terapêutico , Trypanosoma cruzi , Vacinas de DNA/uso terapêutico , Animais , Antígenos de Protozoários/genética , Antígenos de Protozoários/imunologia , Cardiomiopatia Chagásica/patologia , Feminino , Camundongos , Camundongos Endogâmicos ICR , Parasitemia/tratamento farmacológico , Plasmídeos/genética , Vacinas Protozoárias/genética , Vacinas de DNA/genéticaRESUMO
Previous work showed that immunotherapy with a DNA vaccine encoding Trypanosoma cruzi antigen TSA-1 reduced cardiac tissue damage and improved survival in mice when administered during the acute or chronic phases of T. cruzi infection. In the present study, we investigated changes in T-cell populations induced by DNA vaccine immunotherapy. ICR mice were infected with 500 T. cruzi blood trypomastigotes and treated during the acute or chronic phases with two 100 microg doses of DNA vaccine. Analysis of stained splenocytes by flow cytometry indicated that the therapeutic vaccine induced a rapid increase in the number of CD4+ and CD8+ T cells in both the acute and chronic phases. Also, there was a rapid increase in T. cruzi-specific IFNgamma-producing CD8+ T cells following treatment during the chronic phase. The effects of these changes on the control of infection required longer time periods to be detectable but resulted in a reduction in myocarditis and T. cruzi parasite burden in both phases of the infection, as assessed by histopathologic analysis and semi-quantitative PCR detection of T. cruzi in cardiac tissue. These results suggest that DNA vaccines that induce CD8+ T-cells activity and IFNgamma production, would be good candidates for effective therapeutic vaccination against T. cruzi infection.
Assuntos
Doença de Chagas/terapia , Linfócitos T/imunologia , Trypanosoma cruzi/imunologia , Vacinas de DNA/uso terapêutico , Doença Aguda , Animais , Doença de Chagas/imunologia , Doença Crônica , Camundongos , Camundongos Endogâmicos ICR , Fatores de Tempo , Vacinas de DNA/imunologiaRESUMO
BACKGROUND: Chagas disease, caused by the parasite Trypanosoma cruzi, is mainly transmitted by blood-sucking bugs called triatomines. In the Yucatán Peninsula, Mexico, the main vector of T. cruzi is Triatoma dimidiata. While this species may colonize houses in other regions, it is mostly intrusive in Yucatán: it generally lives in sylvan and peridomestic areas, and frequently enters inside homes, likely attracted by potential vertebrate hosts, without establishing colonies. Bugs collected inside homes have a low nutritional status, suggesting that they cannot efficiently feed inside these houses. We hypothesized that this low nutritional status and limited colonization may be associated, at least in part, with the local practice in Mayan communities to sleep in hammocks instead of beds, as this sleeping habit could be an obstacle for triatomines to easily reach human hosts, particularly for nymphal instars which are unable to fly. METHODS: We used an experimental chamber in which we placed a miniature bed in one side and a miniature hammock on the other side. After placing a mouse enclosed in a small cage on the bed and another one in the hammock as baits, T. dimidiata bugs were released in the chamber and their activity was video recorded during the night. RESULTS: T. dimidiata adults and nymphs were able to reach the mouse in bed significantly more often than the mouse in hammock (Binomial test, P < 0.0001). Moreover, females reached the mice twice as often as did males. Most of the adult bugs reached the mouse in bed by walking, while they reached the mouse in hammock by flying. Nymphs presented a host-seeking index ten times lower than adult bugs and were also able, on a few occasions (4/132 released bugs), to reach the mouse in hammock. CONCLUSIONS: We conclude that sleeping in hammocks, as done in rural Yucatán, makes human hosts less accessible to the bugs. This, combined with other factors (e.g. absence of domestic animals sleeping inside houses), may explain, at least in part, the low nutritional status of bugs collected inside homes and the limited colonization of houses by T. dimidiata in the region. Nevertheless, while this sleeping habit limits contact with the bugs, it does not confer complete protection as adult bugs as well as some nymphs were still able to reach the host in hammock in our study.
Assuntos
Comportamento Alimentar , Comportamento de Busca por Hospedeiro , Insetos Vetores , Sono , Triatoma/fisiologia , Animais , México , CamundongosRESUMO
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. In Ecuador, Triatoma dimidiata and Rhodnius ecuadoriensis are the main vector species, responsible for over half of the cases of T. cruzi infection in the country. T. dimidiata is believed to have been introduced in Ecuador during colonial times, and its elimination from the country is thus believed to be feasible. We investigated here the molecular ecology of T. dimidiata and T. cruzi in costal Ecuador to further guide control efforts. Analysis of the Internal Transcribed Spacer 2 (ITS-2) of 23 specimens from Progreso, Guayas, unambiguously supported the likely importation of T. dimidiata from Central America to Ecuador. The observation of a very high parasite infection rate (54%) and frequent feeding on humans (3/5) confirmed a continued risk of transmission to humans. All genotyped parasites corresponded to TcI DTU and Trypanosoma rangeli was not detected in T. dimidiata. TcI subgroups corresponded to TcIa (25%), and mixed infections with TcIa and TcId (75%). Further studies should help clarify T. cruzi genetic structure in the country, and the possible impact of the introduction of T. dimidiata on the circulating parasite strains. The elevated risk posed by this species warrants continuing efforts for its control, but its apparent mobility between peridomestic and domestic habitats may favor reinfestation following insecticide spraying.
Assuntos
Doença de Chagas/transmissão , DNA Intergênico/genética , Espécies Introduzidas , Estágios do Ciclo de Vida/genética , Filogenia , Triatoma/genética , Animais , Doença de Chagas/epidemiologia , Doença de Chagas/parasitologia , Ecossistema , Equador/epidemiologia , Comportamento Alimentar/fisiologia , Feminino , Genótipo , Humanos , Controle de Insetos , Insetos Vetores , Masculino , Epidemiologia Molecular , Rhodnius/parasitologia , Triatoma/classificação , Triatoma/crescimento & desenvolvimento , Triatoma/parasitologia , Trypanosoma cruzi/patogenicidade , Trypanosoma cruzi/fisiologiaRESUMO
Parasitic diseases cause â¼ 500,000 deaths annually and remain a major challenge for therapeutic development. Using a rational design based approach, we developed peptide inhibitors with anti-parasitic activity that were derived from the sequences of parasite scaffold proteins LACK (Leishmania's receptor for activated C-kinase) and TRACK (Trypanosoma receptor for activated C-kinase). We hypothesized that sequences in LACK and TRACK that are conserved in the parasites, but not in the mammalian ortholog, RACK (Receptor for activated C-kinase), may be interaction sites for signaling proteins that are critical for the parasites' viability. One of these peptides exhibited leishmanicidal and trypanocidal activity in culture. Moreover, in infected mice, this peptide was also effective in reducing parasitemia and increasing survival without toxic effects. The identified peptide is a promising new anti-parasitic drug lead, as its unique features may limit toxicity and drug-resistance, thus overcoming central limitations of most anti-parasitic drugs.
Assuntos
Leishmania/efeitos dos fármacos , Peptídeos/síntese química , Peptídeos/farmacologia , Proteínas de Protozoários/antagonistas & inibidores , Receptores de Superfície Celular/antagonistas & inibidores , Tripanossomicidas/farmacologia , Trypanosoma/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Antígenos de Protozoários/química , Desenho de Fármacos , Leishmania/química , Leishmania/genética , Leishmaniose/tratamento farmacológico , Leishmaniose/parasitologia , Camundongos , Parasitemia/tratamento farmacológico , Peptídeos/administração & dosagem , Proteínas de Protozoários/química , Receptores de Quinase C Ativada , Receptores de Superfície Celular/química , Alinhamento de Sequência , Tripanossomicidas/administração & dosagem , Tripanossomicidas/química , Trypanosoma/genética , Tripanossomíase/tratamento farmacológico , Tripanossomíase/parasitologiaRESUMO
Hurricanes can have devastating effects on health and may directly modulate vector-borne diseases. Chagas disease is a zoonosis caused by the protozoan parasite Trypanosoma cruzi and transmitted by triatomine bugs, and the effect of hurricanes on these bugs is largely unknown. We thus performed a detailed study of the changes in Triatoma dimidiata geographic distribution and infection rates after Hurricane Isidore devastated the Yucatán Peninsula in September 2002. Bugs were collected in 34 villages from the entire peninsula, during a year, starting 3 months after the hurricane. Pre- and posthurricane bug collections were compared to assess changes. The most notable effect was a large increase in domestic abundance of T. dimidiata during the 6 months after the hurricane. This increase was maximum along the path of the hurricane. These results suggest that vector control programs should be implemented along the path of hurricanes to prevent an increase in Chagas disease transmission risk in the ensuing months.
Assuntos
Doença de Chagas/epidemiologia , Doença de Chagas/transmissão , Desastres , Insetos Vetores/parasitologia , Triatoma/parasitologia , Trypanosoma cruzi/patogenicidade , Animais , Doença de Chagas/etiologia , Humanos , México/epidemiologia , Fatores de Risco , Estações do AnoRESUMO
BACKGROUND: Non-domiciliated (intrusive) triatomine vectors remain a challenge for the sustainability of Chagas disease vector control as these triatomines are able to transiently (re-)infest houses. One of the best-characterized examples is Triatoma dimidiata from the Yucatan peninsula, Mexico, where adult insects seasonally infest houses between March and July. METHODS: We focused our study on three rural villages in the state of Yucatan, Mexico, in which we performed a situation analysis as a first step before the implementation of an ecohealth (ecosystem approach to health) vector control intervention. RESULTS: The identification of the key determinants affecting the transient invasion of human dwellings by T. dimidiata was performed by exploring associations between bug presence and qualitative and quantitative variables describing the ecological, biological and social context of the communities. We then used a participatory action research approach for implementation and evaluation of a control strategy based on window insect screens to reduce house infestation by T. dimidiata. CONCLUSIONS: This ecohealth approach may represent a valuable alternative to vertically-organized insecticide spraying. Further evaluation may confirm that it is sustainable and provides effective control (in the sense of limiting infestation of human dwellings and vector/human contacts) of intrusive triatomines in the region.